Krystyna Widecka

Expert consensus for the diagnosis and treatment of patients with hyperuricemia and high cardiovascular risk: 2025 update

Richard Johnson, I Gruev, Yoto Yotov, Peter Jackuliak et autres

BACKGROUND: Hyperuricemia has traditionally been viewed primarily as a cause of gout; however, accumulating evidence indicates that elevated serum uric acid (sUA) is also associated with increased cardiovascular and renal risk. Recent epidemiological studies suggest that adverse outcomes may occur at sUA …

us, bg, sk, it, pl, hu, cz, ro (code pays fourni par la source)

Assessment of IL-8, RANTES, MIG, MCP-1, IP-10, and IL-12p70 and Their Association with Anxiety and Quality of Life in Patients with Chronic Kidney Disease or After Kidney Transplantation

Gabriela Furtak, Natalia Lerch, Mateusz Kozłowski, Piotr Tkacz et autres

Anxiety is a subjective feeling of fear in response to stressful or threatening situations. Chronic diseases (such as chronic kidney disease) or the state after kidney transplantation are such situations and they may result in a decreased quality of life. The main …

pl (code pays fourni par la source)

Leczenie dyslipidemii w Polsce — interdyscyplinarne stanowisko grupy ekspertów wsparte przez Sekcję Farmakoterapii Sercowo-Naczyniowej Polskiego Towarzystwa Kardiologicznego. IV Deklaracja Sopocka

Filip M. Szymański, Agnieszka Mickiewicz, Grzegorz Jan Dzida, Dariusz Kozłowski et autres

pl (code pays fourni par la source)

Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update

Claudio Borghi, Justyna Domienik‐Karłowicz, Andrzej Tykarski, Krystyna Widecka et autres

While fundamental concepts outlined in the 2018 consensus [1] will be revisited, emphasis will be placed on the more recent developments.

it, pl (code pays fourni par la source)

Risk factors and potential outcomes of COVID-2019 — a narrative review with focus on cardiovascular health

Anna Ryś-Czaporowska, Krystyna Widecka, Karolina Semczuk-Kaczmarek, Anna Edyta Platek et autres

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2), spreads rapidly and has been announced a pandemic by the World Health Organization (WHO). COVID-19 especially affects cardiovascular system, mostly by leading to the dysfunction of endothelium and its consequences. …

pl (code pays fourni par la source)

Systematic and Multidisciplinary Evaluation of Fibromuscular Dysplasia Patients Reveals High Prevalence of Previously Undetected Fibromuscular Dysplasia Lesions and Affects Clinical Decisions

Ewa Warchoł-Celińska, Aleksander Prejbisz, Piotr Dobrowolski, Anna Klisiewicz et autres

Fibromuscular dysplasia (FMD), regarded as a generalized vascular disease, may affect all vascular beds and may result in arterial stenosis, occlusion, aneurysm, or dissection. It has been proposed to systematically evaluate all vascular beds in patients with FMD, regardless of initial FMD …

pl (code pays fourni par la source)

2019 Guidelines for the Management of Hypertension — Part 8–9

Andrzej Tykarski, Krzysztof Jerzy Filipiak, Andrzej Januszewicz, Mieczysław Litwin et autres

RECOMMENDATIONS OF THE POLISH SOCIETY OF HYPERTENSION GUIDELINE EDITORS: Andrzej Tykarski, Krzysztof J. Filipiak, Andrzej Januszewicz, Mieczysław Litwin, Krzysztof Narkiewicz, Aleksander Prejbisz, Danuta Ostalska-Nowicka, Krystyna Widecka, Katarzyna Kostka-Jeziorny EXPERTS: Marcin Adamczak, Marta Buraczewska, Ludwina Szczepaniak-Chicheł, Marzena Chrostowska, Danuta Czarnecka, Piotr Dobrowolski, Grzegorz …

Dimensions of neurotic personality and its selected predictors in individuals with arterial hypertension

Małgorzata Szczęśniak, Joanna Furmańska, Krystian Konieczny, Krystyna Widecka et autres

OBJECTIVES: To assess of the levels of neurotic personality dimensions in a group of patients with arterial hypertension compared to healthy individuals. To test the relationship between the overall neurotic personality score and satisfaction with life as well as tendency to notice …

pl (code pays fourni par la source)

2019 Guidelines for the Management of Hypertension — Part 1–7

Andrzej Tykarski, Krzysztof Jerzy Filipiak, Andrzej Januszewicz, Mieczysław Litwin et autres

RECOMMENDATIONS OF THE POLISH SOCIETY OF HYPERTENSION GUIDELINE EDITORS: Andrzej Tykarski, Krzysztof J. Filipiak, Andrzej Januszewicz, Mieczysław Litwin, Krzysztof Narkiewicz, Aleksander Prejbisz, Danuta Ostalska-Nowicka, Krystyna Widecka, Katarzyna Kostka-Jeziorny EXPERTS: Marcin Adamczak, Marta Buraczewska, Ludwina Szczepaniak-Chicheł, Marzena Chrostowska, Danuta Czarnecka, Piotr Dobrowolski, Grzegorz …

IMPACT OF SYSTEMATIC AND MULTIDISCIPLINARY EVALUATION OF FMD PATIENTS ON NUMBER OF NEWLY REVEALED FMD LESIONS AND COMPLICATIONS -POLISH ARCADIA-POL STUDY

Ewa Warchoł-Celińska, Aleksander Prejbisz, Elżbieta Florczak, Magdalena Januszewicz et autres

Objective: Analysis of large cohorts of FMD patients allowed to reevaluate fibromuscular dysplasia (FMD) as a systemic arteriopathy. The aim of this analysis is to evaluate to what extent systematic and multidisciplinary evaluation of FMD patients results in novel FMD findings and …

pl (code pays fourni par la source)

Study of epidemiological aspects of hyperuricemia in Poland

Katarzyna Kostka-Jeziorny, Krystyna Widecka, Andrzej Tykarski

BACKGROUND: The results of the latest epidemiological studies show that the problem of hyperuricemia affects many millions of people. The main purpose of the study was to assess the knowledge of physicians with regard to the epidemiology and treatment of hyperuricemia in …

pl (code pays fourni par la source)

Nowy paradygmat leczenia przeciwzakrzepowego chorób miażdżycowych. Stanowisko grupy ekspertów wsparte przez Sekcję Farmakoterapii Sercowo-Naczyniowej Polskiego Towarzystwa Kardiologicznego dotyczące miejsca riwaroksabanu w terapii stabilnej choroby wieńcowej lub objawowej choroby tętnic obwodowych

Marcin Barylski, Artur Mamcarz, Janusz Siebert, Filip M. Szymański et autres

The need to improve the efficacy of anticoagulant therapy in secondary prevention is indicated by the fact that intensive antiplatelet therapy only partially reduces cardiovascular risk. The results of the COMPASS study provide evidence that additional blocking of coagulation cascade may significantly …

pl (code pays fourni par la source)